Guardant Health
GH
$18.10
Share price
4.38%
Change (1 day)
-21.54%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Market capitalization of Guardant Health (GH)
Market cap: $2.20 Billion
As of April 2024 Guardant Health has a market cap of $2.20 Billion. This makes Guardant Health the world's 3945th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Guardant Health from 2018 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.20 B | -32.9% |
| 2023 | $3.28 B | 17.84% |
| 2022 | $2.78 B | -72.6% |
| 2021 | $10.16 B | -21.09% |
| 2020 | $12.88 B | 75.59% |
| 2019 | $7.33 B | 127.64% |
| 2018 | $3.22 B |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of Guardant Health was reported to be:
$2.20 Billion
$2.20 Billion
$2.20 Billion
$2.20 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | $2.67 B | 21.63% | 🇺🇸 USA |
 Natera NTRA | $11.04 B | 401.56% | 🇺🇸 USA |